Breast cancer stem cell enrichment and isolation by mammosphere culture and its potential diagnostic applications

Expert Review of Molecular Diagnostics

Volumn 13, Issue 1, 2013, Pages 49-60

  Saadin, Katayoon ^a   White, Ian M ^a,b  

^a UNIVERSITY OF MARYLAND   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

Author keywords

breast cancer; cancer stem cell; mammosphere; metastasis; microsystem

Indexed keywords

DIMETICONE; DOXORUBICIN; MACROGOL; PACLITAXEL; PACLITAXEL DERIVATIVE; POLYCARBONATE; SALINOMYCIN; SBT 1214; TRANILAST; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; AUTOMATION; BREAST CANCER; BREAST CELL; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STEM CELL; CELL ADHESION; CELL CULTURE; CELL DIFFERENTIATION; CELL ISOLATION; CELL STRAIN MCF 7; CIRCULATING TUMOR CELL; CULTURE MEDIUM; CULTURE TECHNIQUE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DRUG EFFICACY; ENRICHMENT CULTURE; FLUORESCENCE ACTIVATED CELL SORTING; HIGH THROUGHPUT SCREENING; HUMAN; HYDROGEL; LAB ON A CHIP; MAMMOSPHERE; MEMBRANE; METASTASIS; MICROFLUIDICS; POLYMERASE CHAIN REACTION; REVIEW; TREATMENT PLANNING; TUMOR BIOPSY;

BREAST NEOPLASMS; CELL CULTURE TECHNIQUES; CELL SEPARATION; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASTIC STEM CELLS; TUMOR MARKERS, BIOLOGICAL; WNT SIGNALING PATHWAY;

EID: 84871578405     PISSN: 14737159     EISSN: 17448352     Source Type: Journal    
DOI: 10.1586/erm.12.117     Document Type: Review

References (112)

1. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature 414(6859), 105-111 (2001).
2. Pardal R, Clarke MF, Morrison SJ. Applying the principles of stem-cell biology to cancer. Nat. Rev. Cancer 3(12), 895-902 (2003).
3. Smalley M, Ashworth A. Stem cells and breast cancer: a field in transit. Nat. Rev. Cancer 3(11), 832-844 (2003).
4. Stingl J, Caldas C. Molecular heterogeneity of breast carcinomas and the cancer stem cell hypothesis. Nat. Rev. Cancer 7(10), 791-799 (2007).
5. Shackleton M, Quintana E, Fearon ER, Morrison SJ. Heterogeneity in cancer: cancer stem cells versus clonal evolution. Cell 138(5), 822-829 (2009).
6. Lapidot T, Sirard C, Vormoor J et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367(6464), 645-648 (1994).
7. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc. Natl Acad. Sci. USA 100(7), 3983-3988 (2003).
8. Ponti D, Costa A, Zaffaroni N et al. Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res. 65(13), 5506-5511 (2005).
9. Hemmati HD, Nakano I, Lazareff JA et al. Cancerous stem cells can arise from pediatric brain tumors. Proc. Natl Acad. Sci. USA 100(25), 15178-15183 (2003).
10. Singh SK, Clarke ID, Terasaki M et al. Identification of a cancer stem cell in human brain tumors. Cancer Res. 63(18), 5821-5828 (2003).
11. Fang D, Nguyen TK, Leishear K et al. A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Res. 65(20), 9328-9337 (2005).
12. Li C, Heidt DG, Dalerba P et al. Identification of pancreatic cancer stem cells. Cancer Res. 67(3), 1030-1037 (2007).
13. Kondo T, Setoguchi T, Taga T. Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. Proc. Natl Acad. Sci. USA 101(3), 781-786 (2004).
14. Rappa G, Mercapide J, Anzanello F et al. Growth of cancer cell lines under stem cell-like conditions has the potential to unveil therapeutic targets. Exp. Cell Res. 314(10), 2110-2122 (2008).
15. Dean M, Fojo T, Bates S. Tumour stem cells and drug resistance. Nat. Rev. Cancer 5(4), 275-284 (2005).
16. Dean M, Rzhetsky A, Allikmets R. The human ATP-binding cassette (ABC) transporter superfamily. Genome Res. 11(7), 1156-1166 (2001).
17. Goodell MA, Rosenzweig M, Kim H et al. Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species. Nat. Med. 3(12), 1337-1345 (1997).
18. Gupta PB, Onder TT, Jiang G et al. Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell 138(4), 645-659 (2009).
19. Li X, Lewis MT, Huang J et al. Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. J. Natl Cancer Inst. 100(9), 672-679 (2008).
20. Diehn M, Cho RW, Lobo NA et al. Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature 458(7239), 780-783 (2009).
21. Li F, Tiede B, Massagué J, Kang Y. Beyond tumorigenesis: cancer stem cells in metastasis. Cell Res. 17(1), 3-14 (2007).
22. Li Y, Welm B, Podsypanina K et al. Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells. Proc. Natl Acad. Sci. USA 100(26), 15853-15858 (2003).
23. Katoh M. Networking of WNT, FGF, Notch, BMP, and Hedgehog signaling pathways during carcinogenesis. Stem Cell Rev. 3(1), 30-38 (2007).
24. Vermeulen L, De Sousa E Melo F, van der Heijden M et al. Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nat. Cell Biol. 12(5), 468-476 (2010).
25. Katoh M. Network of WNT and other regulatory signaling cascades in pluripotent stem cells and cancer stem cells. Curr. Pharm. Biotechnol. 12(2), 160-170 (2011).
26. Mani SA, Guo W, Liao MJ et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133(4), 704-715 (2008).
27. Morel AP, Lièvre M, Thomas C, Hinkal G, Ansieau S, Puisieux A. Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS ONE 3(8), e2888 (2008).
28. Lakhani SR, Van De Vijver MJ, Jacquemier J et al. The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2. J. Clin. Oncol. 20(9), 2310-2318 (2002).
29. Bauer KR, Brown M, Cress RD, Parise CA, Caggiano V. Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California Cancer Registry. Cancer 109(9), 1721-1728 (2007).
30. Onitilo AA, Engel JM, Greenlee RT, Mukesh BN. Breast cancer subtypes based on ER/PR and Her2 expression: comparison of clinicopathologic features and survival. Clin. Med. Res. 7(1-2), 4-13 (2009).
31. Dontu G, Abdallah WM, Foley JM et al. In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev. 17(10), 1253-1270 (2003).
32. Vescovi AL, Reynolds BA, Fraser DD, Weiss S. bFGF regulates the proliferative fate of unipotent (neuronal) and bipotent (neuronal/astroglial) EGF-generated CNS progenitor cells. Neuron 11(5), 951-966 (1993).
33. Reynolds BA, Weiss S. Clonal and population analyses demonstrate that an EGF-responsive mammalian embryonic CNS precursor is a stem cell. Dev. Biol. 175(1), 1-13 (1996).
34. Grimshaw MJ, Cooper L, Papazisis K et al. Mammosphere culture of metastatic breast cancer cells enriches for tumorigenic breast cancer cells. Breast Cancer Res. 10(3), R52 (2008).
35. Lawson DA, Xin L, Lukacs RU, Cheng D, Witte ON. Isolation and functional characterization of murine prostate stem cells. Proc. Natl Acad. Sci. USA 104(1), 181-186 (2007).
36. Ginestier C, Hur MH, Charafe-Jauffret E et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 1(5), 555-567 (2007).
37. Cicalese A, Bonizzi G, Pasi CE et al. The tumor suppressor p53 regulates polarity of self-renewing divisions in mammary stem cells. Cell 138(6), 1083-1095 (2009).
38. Tirino V, Camerlingo R, Franco R et al. The role of CD133 in the identification and characterisation of tumour-initiating cells in non-small-cell lung cancer. Eur. J. Cardiothorac. Surg. 36(3), 446-453 (2009).
39. Liu S, Dontu G, Mantle ID et al. Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. Cancer Res. 66(12), 6063-6071 (2006).
40. Charafe-Jauffret E, Ginestier C, Iovino F et al. Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature. Cancer Res. 69(4), 1302-1313 (2009).
41. Fillmore CM, Gupta PB, Rudnick JA et al. Estrogen expands breast cancer stem-like cells through paracrine FGF/Tbx3 signaling. Proc. Natl Acad. Sci. USA 107(50), 21737-21742 (2010).
42. Wang XY, Penalva LO, Yuan H et al. Musashi1 regulates breast tumor cell proliferation and is a prognostic indicator of poor survival. Mol. Cancer 9, 221 (2010).
43. Chiou SH, Wang ML, Chou YT et al. Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation. Cancer Res. 70(24), 10433-10444 (2010).
44. Bandyopadhyay A, Wang L, Agyin J et al. Doxorubicin in combination with a small TGF-β inhibitor: a potential novel therapy for metastatic breast cancer in mouse models. PLoS ONE 5(4), e10365 (2010).
45. Li Y, Zhang T, Korkaya H et al. Sulforaphane, a dietary component of broccoli/broccoli sprouts, inhibits breast cancer stem cells. Clin. Cancer Res. 16(9), 2580-2590 (2010).
46. Prud'homme GJ, Glinka Y, Toulina A, Ace O, Subramaniam V, Jothy S. Breast cancer stem-like cells are inhibited by a non-toxic aryl hydrocarbon receptor agonist. PLoS ONE 5(11), e13831 (2010).
47. Botchkina GI, Zuniga ES, Das M et al. New-generation taxoid SB-T-1214 inhibits stem cell-related gene expression in 3D cancer spheroids induced by purified colon tumor-initiating cells. Mol. Cancer 9, 192 (2010).
48. Nagrath S, Sequist LV, Maheswaran S et al. Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature 450(7173), 1235-1239 (2007).
49. Adams AA, Okagbare PI, Feng J et al. Highly efficient circulating tumor cell isolation from whole blood and label-free enumeration using polymer-based microfluidics with an integrated conductivity sensor. J. Am. Chem. Soc. 130(27), 8633-8641 (2008).
50. Talasaz AH, Powell AA, Huber DE et al. Isolating highly enriched populations of circulating epithelial cells and other rare cells from blood using a magnetic sweeper device. Proc. Natl Acad. Sci. USA 106(10), 3970-3975 (2009).
51. Saliba AE, Saias L, Psychari E et al. Microfluidic sorting and multimodal typing of cancer cells in self-assembled magnetic arrays. Proc. Natl Acad. Sci. USA 107(33), 14524-14529 (2010).
52. Stott SL, Hsu CH, Tsukrov DI et al. Isolation of circulating tumor cells using a microvortex-generating herringbone-chip. Proc. Natl Acad. Sci. USA 107(43), 18392-18397 (2010).
53. Schmidt-Kittler O, Ragg T, Daskalakis A et al. From latent disseminated cells to overt metastasis: genetic analysis of systemic breast cancer progression. Proc. Natl Acad. Sci. USA 100(13), 7737-7742 (2003).
54. Meng S, Tripathy D, Frenkel EP et al. Circulating tumor cells in patients with breast cancer dormancy. Clin. Cancer Res. 10(24), 8152-8162 (2004).
55. Budd GT, Cristofanilli M, Ellis MJ et al. Circulating tumor cells versus imaging-predicting overall survival in metastatic breast cancer. Clin. Cancer Res. 12(21), 6403-6409 (2006).
56. Smerage JB, Hayes DF. The measurement and therapeutic implications of circulating tumour cells in breast cancer. Br. J. Cancer 94(1), 8-12 (2006).
57. Wülfing P, Borchard J, Buerger H et al. HER2-positive circulating tumor cells indicate poor clinical outcome in stage I to III breast cancer patients. Clin. Cancer Res. 12(6), 1715-1720 (2006).
58. Paterlini-Brechot P, Benali NL. Circulating tumor cells (CTC) detection: clinical impact and future directions. Cancer Lett. 253(2), 180-204 (2007).
59. Cohen SJ, Punt CJ, Iannotti N et al. Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. J. Clin. Oncol. 26(19), 3213-3221 (2008).
60. Maheswaran S, Sequist LV, Nagrath S et al. Detection of mutations in EGFR in circulating lung-cancer cells. N. Engl. J. Med. 359(4), 366-377 (2008).
61. Yager P, Edwards T, Fu E et al. Microfluidic diagnostic technologies for global public health. Nature 442(7101), 412-418 (2006).
62. Chin CD, Linder V, Sia SK. Lab-on-a-chip devices for global health: past studies and future opportunities. Lab Chip 7(1), 41-57 (2007).
63. Myers FB, Lee LP. Innovations in optical microfluidic technologies for point-of-care diagnostics. Lab Chip 8(12), 2015-2031 (2008).
64. Xu G, Hsieh TM, Lee DY et al. A self-contained all-in-one cartridge for sample preparation and real-time PCR in rapid influenza diagnosis. Lab Chip 10(22), 3103-3111 (2010).
65. Sun Y, Dhumpa R, Bang DD, Høgberg J, Handberg K, Wolff A. A lab-on-a-chip device for rapid identification of avian influenza viral RNA by solid-phase PCR. Lab Chip 11(8), 1457-1463 (2011).
66. Wang CH, Lien KY, Wu JJ, Lee GB. A magnetic bead-based assay for the rapid detection of methicillin-resistant Staphylococcus aureus by using a microfluidic system with integrated loop-mediated isothermal amplification. Lab Chip 11(8), 1521-1531 (2011).
67. Nagatani N, Yamanaka K, Ushijima H et al. Detection of influenza virus using a lateral flow immunoassay for amplified DNA by a microfluidic RT-PCR chip. Analyst 137(15), 3422-3426 (2012).
68. Verdoy D, Barrenetxea Z, Berganzo J et al. A novel real time micro PCR based point-of-care device for Salmonella detection in human clinical samples. Biosens. Bioelectron. 32(1), 259-265 (2012).
69. Zheng G, Patolsky F, Cui Y, Wang WU, Lieber CM. Multiplexed electrical detection of cancer markers with nanowire sensor arrays. Nat. Biotechnol. 23(10), 1294-1301 (2005).
70. Fan R, Vermesh O, Srivastava A et al. Integrated barcode chips for rapid, multiplexed analysis of proteins in microliter quantities of blood. Nat. Biotechnol. 26(12), 1373-1378 (2008).
71. Stevens DY, Petri CR, Osborn JL, Spicar-Mihalic P, McKenzie KG, Yager P. Enabling a microfluidic immunoassay for the developing world by integration of on-card dry reagent storage. Lab Chip 8(12), 2038-2045 (2008).
72. Lee BS, Lee JN, Park JM et al. A fully automated immunoassay from whole blood on a disc. Lab Chip 9(11), 1548-1555 (2009).
73. Washburn AL, Luchansky MS, Bowman AL, Bailey RC. Quantitative, label-free detection of five protein biomarkers using multiplexed arrays of silicon photonic microring resonators. Anal. Chem. 82(1), 69-72 (2010).
74. Ouellet E, Lausted C, Lin T, Yang CW, Hood L, Lagally ET. Parallel microfluidic surface plasmon resonance imaging arrays. Lab Chip 10(5), 581-588 (2010).
75. Schumacher S, Nestler J, Otto T et al. Highly-integrated lab-on-chip system for point-of-care multiparameter analysis. Lab Chip 12(3), 464-473 (2012).
76. Reedy CR, Price CW, Sniegowski J, Ferrance JP, Begley M, Landers JP. Solid phase extraction of DNA from biological samples in a post-based, high surface area poly(methyl methacrylate) (PMMA) microdevice. Lab Chip 11(9), 1603-1611 (2011).
77. Root BE, Agarwal AK, Kelso DM, Barron AE. Purification of HIV RNA from serum using a polymer capture matrix in a microfluidic device. Anal. Chem. 83(3), 982-988 (2011).
78. Duarte GR, Price CW, Littlewood JL et al. Characterization of dynamic solid phase DNA extraction from blood with magnetically controlled silica beads. Analyst 135(3), 531-537 (2010).
79. Price CW, Leslie DC, Landers JP. Nucleic acid extraction techniques and application to the microchip. Lab Chip 9(17), 2484-2494 (2009).
80. Kim J, Gale BK. Quantitative and qualitative analysis of a microfluidic DNA extraction system using a nanoporous AlO(x) membrane. Lab Chip 8(9), 1516-1523 (2008).
81. Cho YK, Lee JG, Park JM, Lee BS, Lee Y, Ko C. One-step pathogen specific DNA extraction from whole blood on a centrifugal microfluidic device. Lab Chip 7(5), 565-573 (2007).
82. Dertinger SKW, Chiu DT, Jeon NL, Whitesides GM. Generation of gradients having complex shapes using microfluidic networks. Anal. Chem. 73(6), 1240-1246 (2001).
83. Li Jeon N, Baskaran H, Dertinger SK, Whitesides GM, Van de Water L, Toner M. Neutrophil chemotaxis in linear and complex gradients of interleukin-8 formed in a microfabricated device. Nat. Biotechnol. 20(8), 826-830 (2002).
84. Walsh CL, Babin BM, Kasinskas RW, Foster JA, McGarry MJ, Forbes NS. A multipurpose microfluidic device designed to mimic microenvironment gradients and develop targeted cancer therapeutics. Lab Chip 9(4), 545-554 (2009).
85. Atencia J, Cooksey GA, Locascio LE. A robust diffusion-based gradient generator for dynamic cell assays. Lab Chip 12(2), 309-316 (2012).
86. Wlodkowic D, Cooper JM. Tumors on chips: oncology meets microfluidics. Curr. Opin. Chem. Biol. 14(5), 556-567 (2010).
87. Young EW, Beebe DJ. Fundamentals of microfluidic cell culture in controlled microenvironments. Chem. Soc. Rev. 39(3), 1036-1048 (2010).
88. El-Ali J, Sorger PK, Jensen KF. Cells on chips. Nature 442(7101), 403-411 (2006).
89. Wu MH, Huang SB, Lee GB. Microfluidic cell culture systems for drug research. Lab Chip 10(8), 939-956 (2010).
90. Sung JH, Shuler ML. A micro cell culture analog (microCCA) with 3-D hydrogel culture of multiple cell lines to assess metabolism-dependent cytotoxicity of anti-cancer drugs. Lab Chip 9(10), 1385-1394 (2009).
91. Hsiao AY, Torisawa YS, Tung YC et al. Microfluidic system for formation of PC-3 prostate cancer co-culture spheroids. Biomaterials 30(16), 3020-3027 (2009).
92. Meyvantsson I, Warrick JW, Hayes S, Skoien A, Beebe DJ. Automated cell culture in high density tubeless microfluidic device arrays. Lab Chip 8(5), 717-724 (2008).
93. Zhou Y, Pang Y, Huang Y. Openly accessible microfluidic liquid handlers for automated high-throughput nanoliter cell culture. Anal. Chem. 84(5), 2576-2584 (2012).
94. Fukazawa H, Mizuno S, Uehara Y. A microplate assay for quantitation of anchorage-independent growth of transformed cells. Anal. Biochem. 228(1), 83-90 (1995).
95. Prime KL, Whitesides GM. Self-assembled organic monolayers: model systems for studying adsorption of proteins at surfaces. Science 252(5010), 1164-1167 (1991).
96. Lee SW, Laibinis PE. Protein-resistant coatings for glass and metal oxide surfaces derived from oligo(ethylene glycol)-terminated alkytrichlorosilanes. Biomaterials 19(18), 1669-1675 (1998).
97. Revzin A, Tompkins RG, Toner M. Surface engineering with poly(ethylene glycol) photolithography to create high-density cell arrays on glass. Langmuir 19(13), 9855-9862 (2003).
98. Mahmood TA, Miot S, Frank O et al. Modulation of chondrocyte phenotype for tissue engineering by designing the biologic-polymer carrier interface. Biomacromolecules 7(11), 3012-3018 (2006).
99. Arima Y, Iwata H. Effect of wettability and surface functional groups on protein adsorption and cell adhesion using well-defined mixed self-assembled monolayers. Biomaterials 28(20), 3074-3082 (2007).
100. Wang YY, Lü LX, Shi JC, Wang HF, Xiao ZD, Huang NP. Introducing RGD peptides on PHBV films through PEG-containing cross-linkers to improve the biocompatibility. Biomacromolecules 12(3), 551-559 (2011).
101. Kim C, Lee KS, Bang JH et al. 3-Dimensional cell culture for on-chip differentiation of stem cells in embryoid body. Lab Chip 11(5), 874-882 (2011).
102. Kang E, Choi YY, Jun Y, Chung BG, Lee SH. Development of a multi-layer microfluidic array chip to culture and replate uniform-sized embryoid bodies without manual cell retrieval. Lab Chip 10(20), 2651-2654 (2010).
103. Davis JA, Inglis DW, Morton KJ et al. Deterministic hydrodynamics: taking blood apart. Proc. Natl Acad. Sci. USA 103(40), 14779-14784 (2006).
104. Choi S, Song S, Choi C, Park JK. Continuous blood cell separation by hydrophoretic filtration. Lab Chip 7(11), 1532-1538 (2007).
105. Han KH, Frazier AB. Lateral-driven continuous dielectrophoretic microseparators for blood cells suspended in a highly conductive medium. Lab Chip 8(7), 1079-1086 (2008).
106. Green JV, Radisic M, Murthy SK. Deterministic lateral displacement as a means to enrich large cells for tissue engineering. Anal. Chem. 81(21), 9178-9182 (2009).
107. Choi S, Song S, Choi C, Park JK. Microfluidic self-sorting of mammalian cells to achieve cell cycle synchrony by hydrophoresis. Anal. Chem. 81(5), 1964-1968 (2009).
108. Lenshof A, Laurell T. Continuous separation of cells and particles in microfluidic systems. Chem. Soc. Rev. 39(3), 1203-1217 (2010).
109. Bhagat AA, Hou HW, Li LD, Lim CT, Han J. Pinched flow coupled shear-modulated inertial microfluidics for high-throughput rare blood cell separation. Lab Chip 11(11), 1870-1878 (2011).
110. Mach AJ, Kim JH, Arshi A, Hur SC, Di Carlo D. Automated cellular sample preparation using a Centrifuge-on-a-Chip. Lab Chip 11(17), 2827-2834 (2011).
111. Moon HS, Kwon K, Kim SI et al. Continuous separation of breast cancer cells from blood samples using multi-orifice flow fractionation (MOFF) and dielectrophoresis (DEP). Lab Chip 11(6), 1118-1125 (2011).
112. den Toonder J. Circulating tumor cells: the Grand Challenge. Lab Chip 11(3), 375-377 (2011).